Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Why Investors Are Selling These 5 Stocks Today

Page 1 of 2

In what has been another red day for the S&P 500, with it down by almost 0.4%, shares of KapStone Paper and Packaging Corp. (NYSE:KS), WestRock Co (NYSE:WRK), Zafgen Inc (NASDAQ:ZFGN), Packaging Corp Of America (NYSE:PKG), and Genesis Healthcare Inc (NYSE:GEN) have declined even further. Let’s find out why investors are selling these five stocks today as well as what relevant hedge funds have to say about them.

At Insider Monkey, we track around 730 hedge funds and institutional investors. Through extensive backtests, we have determined that imitating some of the stocks that these investors are collectively bullish on can help retail investors generate double digits of alpha per year. The key is to focus on the small-cap picks of these funds, which are usually less followed by the broader market and allow for larger price inefficiencies (see more details here about our small-cap strategy).

First on the list is KapStone Paper and Packaging Corp. (NYSE:KS), the shares of which have plummeted by 20% after analysts at Macquarie downgraded the paper and packaging company to ‘Underperfom’ from ‘Neutral’. Similarly, WestRock Co (NYSE:WRK) is 13% in the red after analysts at Bank of America downgraded the firm to ‘Hold’ from ‘Buy’. Both companies suffered poor performance over the past twelve months, with shares of KapStone down by 43%, while WestRock’s stock has declined by


Follow Kapstone Paper & Packaging Corp (NYSE:KS)
Trade (NYSE:KS) Now!

Hedge fund sentiment stayed steady in KapStone Paper and Packaging Corp. (NYSE:KS) during the third quarter, as the number of funds in our system long the stock remained unchanged at 24. D E Shaw was the largest shareholder of KapStone Paper and Packaging in our system, with 2.89 million shares valued at $47.78 million at the end of September.

On the other hand, hedge funds were extremely optimistic about WestRock Co (NYSE:WRK), with 42 funds long the stock at the end of the third quarter, up from only one shareholder long the stock at the close of the second quarter. Among the believers was Anand Parekh‘s Alyeska Investment Group, with a holding of 518,415 shares at the end of September.

Follow Westrock Co (NYSE:WRK)
Trade (NYSE:WRK) Now!

Moving on, Zafgen Inc (NASDAQ:ZFGN) has lost 7% after hedge fund Kerrisdale Capital, which is one of the few funds that reveals its short positions, said it was now shorting Zafgen Inc on the belief that regulators in the U.S will not approve Zafgen’s obesity drug beloranib for sale in the country. Days ago, the company announced positive results from its Phase 3 clinical trial of that product, which demonstrated positive effects in the reduction of body weight in patients with Prader-Willi syndrome. However, two patients died while taking the treatment last year, which is enough for Kerrisdale to believe the drug has no chance of approval.

During the third quarter, Zafgen Inc (NASDAQ:ZFGN) registered an increase in popularity among the funds we track, with 14 investors holding long positions at the end of September, versus 12 funds a quarter earlier. James E. Flynn‘s Deerfield Management was the largest shareholder of Zafgen Inc (NASDAQ:ZFGN) in our system, owning 553,472 shares, valued at $17.68 million at the end of September.

Follow Zafgen Inc. (NASDAQ:ZFGN)
Trade (NASDAQ:ZFGN) Now!

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!